Literature DB >> 168468

A new approach to the structure-activity relationship for ACTH analogs using isolated adrenal cortex cells.

S Seelig, B D Lindley, G Sayers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168468     DOI: 10.1016/s0076-6879(75)39031-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  7 in total

1.  Approaches to the rational design of selective melanocortin receptor antagonists.

Authors:  Victor J Hruby; Minying Cai; Joel Nyberg; Dhanasekaran Muthu
Journal:  Expert Opin Drug Discov       Date:  2011-03-24       Impact factor: 6.098

2.  Effects of ACTH (corticotropin) analogues on steroidogenesis and cyclic AMP in rat adrenocortical cells. Evidence for two different steroidogenically responsive receptors.

Authors:  A F Bristow; C Gleed; J L Fauchère; R Schwyzer; D Schulster
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

3.  ACTH-induced lipolysis in rat adipocytes: structure-activity relationships.

Authors:  F A Opmeer; J M van Ree; D de Wied
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

4.  Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells.

Authors:  B Jasani; G Kreil; B F Mackler; D R Stanworth
Journal:  Biochem J       Date:  1979-09-01       Impact factor: 3.857

5.  Adrenocortical response to corticotropin is potentiated by part of the amino-terminal region of pro-corticotropin/endorphin.

Authors:  R C Pedersen; A C Brownie
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  Adrenal cortex adenylate cyclase. In vitro acitivity of ACTH fragments and analogues.

Authors:  H Glossmann; C J Struck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-08       Impact factor: 3.000

Review 7.  From Bioinactive ACTH to ACTH Antagonist: The Clinical Perspective.

Authors:  Chiraz Ghaddhab; Jean-Marc Vuissoz; Johnny Deladoëy
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-08       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.